NCT04854629 is a NA clinical trial of Spinomed active in Osteopenia, sponsored by University of Erlangen-Nürnberg Medical School.

Who is sponsoring NCT04854629?

NCT04854629 is sponsored by University of Erlangen-Nürnberg Medical School.

What drugs are being tested in NCT04854629?

Interventions in NCT04854629: Spinomed active.

What condition does NCT04854629 study?

NCT04854629 studies Osteopenia, Kyphosis.

Is NCT04854629 still recruiting?

NCT04854629 is currently completed. Last updated 19 January 2022.

Last reviewed 2022-01-19 · How we verify

NCT04854629

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of the "Spinomed Active" Orthosis on Chronic Back Pain in Women With Vertebral Fractures.

Completed NA Last updated 19 January 2022

What this trial tests

NA trial testing Spinomed active in Osteopenia in 80 participants. Completed in 15 January 2022.

Timeline

7 April 2021

Primary endpoint
15 December 2021

15 January 2022

Quick facts

Lead sponsor	University of Erlangen-Nürnberg Medical School
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	80
Start date	7 April 2021
Primary completion	15 December 2021
Estimated completion	15 January 2022
Sites	1 location across Germany

Drugs / interventions tested

Spinomed active

Conditions studied

Osteopenia — all drugs for Osteopenia →
Kyphosis — all drugs for Kyphosis →

Sponsor

University of Erlangen-Nürnberg Medical School

Who can join

65 and older, female only, with Osteopenia or Kyphosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Osteoporotic vertebral fractures often lead to postural changes, chronic spinal pain conditions and limited functionality. Orthoses that straighten the spine have been shown in studies to have a positive effect on pain, posture and the functional state of patients with a fresh vertebral fracture. The planned study investigates the effect of the orthosis "Spinomed active" in patients aged ≥ 65 years with at least one non-acute osteoporotic vertebral fracture (at least 3 months ago) and chronic back pain.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of the "Spinomed active" orthosis on chronic back pain in kyphotic women with osteoporotic vertebral fractures three months and older: A randomized controlled study.
Hettchen M, Willert S, von Stengel S, Kohl M, et al · · 2022 · cited 3× · PMID 36618579 · DOI 10.3389/fpain.2022.1038269
Effects of Active Spinal Orthosis on Fatty Infiltration in Paraspinal Muscles in Kyphotic Women with Osteoporotic Vertebral Fracture-Sub-Analysis of a Randomized Controlled Trial.
Hiller M, Kohl M, Chaudry O, Engelke K, et al · · 2025 · PMID 40508875 · DOI 10.3390/healthcare13111262

Verify or expand the search:

Other recruiting trials for Osteopenia

Currently open trials in the same condition.

NCT07473713 — Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia · Phase 1 · recruiting
NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
NCT07187518 — Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device · NA · recruiting
NCT07191353 — Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women · Phase 2 · recruiting

Other University of Erlangen-Nürnberg Medical School trials

Trials by the same sponsor.

NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04854629 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
Last refreshed: 19 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04854629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing